Who owns TRAVERE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Travere Therapeutics stock

Who bought or sold TRAVERE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Exome Asset Management 75k $2.9M 100% Dec 2025
 View chart
Group One Trading 42k $1.6M 7% Dec 2025
 View chart
Simplex Trading 1.7k $65k -97% Dec 2025
 View chart
Persistent Asset Partners 134.00 $9.9k 13300% Dec 2025
 View chart

Who sold out of Travere Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
IMC-Chicago Sep 2025 13k $316k